Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs.

Bernadetta Bielecka Iwona Gorczyca-Głowacka Beata Wożakowska-Kapłon

Published in: International journal of environmental research and public health (2022)

In hospitalized AF patients ≥75 years, dabigatran was the most frequently used NOAC. Age, comorbidities and bleeding risk determined the selection of individual NOACs.

Keyphrases

atrial fibrillation
oral anticoagulants
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
risk factors
patient reported outcomes